• Exchange: NYSE MKT LLC
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Actinium Pharmaceuticals Inc

+ Add to Watchlist

ATNM:US

6.2200 USD 0.0300 0.48%

As of 18:40:03 ET on 08/29/2014.

Snapshot for Actinium Pharmaceuticals Inc (ATNM)

Open: 6.2600 Day's Range: 6.1330 - 6.4800 Volume: 35,867
Previous Close: 6.2500 52wk Range: 3.6000 - 15.0000 1-Yr Rtn: +72.78%

Stock Chart for ATNM

No chart data available.
  • ATNM:US 6.2200
  • 1D
  • 1M
  • 1Y
6.2500
Interactive ATNM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ATNM

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.8667
Est. EPS (USD) (12/2014) -0.9400
Est. PEG Ratio -
Market Cap (M USD) 175.07
Shares Outstanding (M) 28.15
30 Day Average Volume 79,562
Price/Book (mrq) 39.6503
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ATNM

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ATNM

Actinium Pharmaceuticals Inc. operates as a biopharmaceutical company. The Company develops alpha particle immunotherapeutics and other radiopharmaceuticals for select applications.

Kaushik J DavePresident/CEO/Interim CFODragan CicicCOO/Chief Medical Officer
More Company Profile & Key Executives for ATNM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil